HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease.

AbstractBACKGROUND:
The aim of this study was to identify fibrosis-related serological surrogate outcome measures in patients with immunoglobulin G4-related disease (IgG4-RD).
METHODS:
This was a clinical observational study of 72 patients with untreated IgG4-RD from four institutions in Japan. The serum concentrations of growth differentiation factor 15 (GDF-15), CCL2, hyaluronic acid (HA), amino-terminal propeptide of type III procollagen (PIIINP), and tissue inhibitor of metalloproteinases 1 (TIMP-1) were measured by enzyme-linked immunosorbent assays. The enhanced liver fibrosis (ELF) score was calculated from the TIMP-1, PIIINP, and HA values. We evaluated associations between the values of these biomarkers and laboratory data, the IgG4-RD responder index (IgG4-RD RI) score, and organ involvements.
RESULTS:
Compared with the 44 healthy controls, the patients with IgG4-RD showed significantly elevated serum concentrations of GDF-15, MCP-1, HA, PIIINP, and TIMP-1 and ELF scores. The patients' serum concentrations of GDF-15, CCL2, HA, and TIMP-1 (but not PIIINP) were positively correlated with each other. Among them, serum GDF-15 most efficiently distinguished patients with IgG4-RD from healthy controls. Serum GDF-15 was not associated with the IgG4-RD RI score or the number of organ involvements but was independently associated with the presence of retroperitoneal fibrosis and with parotid gland involvement.
CONCLUSIONS:
We observed increased serological surrogate outcome measures of fibrosis in IgG4-RD. GDF-15 may precisely reflect the fibrotic degree in patients with IgG4-RD.
AuthorsShin-Ya Kawashiri, Tomoki Origuchi, Masataka Umeda, Ayako Nishino, Toshimasa Shimizu, Shoichi Fukui, Tomohiro Koga, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Takahiro Maeda, Mitsuhiro Kawano, Motohisa Yamamoto, Yasumori Izumi, Atsushi Kawakami
JournalArthritis research & therapy (Arthritis Res Ther) Vol. 20 Issue 1 Pg. 277 (12 14 2018) ISSN: 1478-6362 [Electronic] England
PMID30547825 (Publication Type: Journal Article, Multicenter Study, Observational Study)
Chemical References
  • Biomarkers
  • CCL2 protein, human
  • Chemokine CCL2
  • GDF15 protein, human
  • Growth Differentiation Factor 15
  • Peptide Fragments
  • Procollagen
  • Tissue Inhibitor of Metalloproteinase-1
  • procollagen Type III-N-terminal peptide
  • Hyaluronic Acid
Topics
  • Aged
  • Biomarkers (blood)
  • Chemokine CCL2 (blood)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Growth Differentiation Factor 15 (blood)
  • Humans
  • Hyaluronic Acid (blood)
  • Immunoglobulin G4-Related Disease (blood, pathology)
  • Liver Cirrhosis (blood, pathology)
  • Male
  • Middle Aged
  • Peptide Fragments (blood)
  • Procollagen (blood)
  • Retrospective Studies
  • Tissue Inhibitor of Metalloproteinase-1 (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: